Management of malignant pleural effusions

Alexandra Dipper, Rahul Bhatnagar, Nick Maskell*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

Abstract

PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options. This article provides a summary of the most up-to-date evidence in this area.

RECENT FINDINGS: Recent publications have demonstrated comparable pleurodesis outcomes of talc slurry to talc poudrage and explore strategies to combine the advantages of indwelling pleural catheters (IPCs) with a chemical pleurodesis. A daily IPC drainage regime improves the chances of pleurodesis success and early IPC removal in patients without significant trapped lung.

SUMMARY: MPE is a diverse condition, with no one strategy representing the 'best' approach for all. Management decisions should be made in conjunction with the patient, taking their views and preferences into consideration.

Original languageEnglish
Pages (from-to)341-345
Number of pages5
JournalCurrent Opinion in Pulmonary Medicine
Volume26
Issue number4
DOIs
Publication statusPublished - 1 Jul 2020

Keywords

  • malignant pleural effusion
  • pleurodesis
  • Indwelling Pleural Catheter
  • IPC

Fingerprint

Dive into the research topics of 'Management of malignant pleural effusions'. Together they form a unique fingerprint.

Cite this